Avodart Might Be Helpful in Preventing Prostate Cancers

Posted by Admin

 

Prostate cancer happens to be one of the most frequent cancers in the world affecting a significant portion of male population after the age of 55. Avodart (dutasteride) is one of the drugs that has cought scientists attention recently regarding the treatment of prostate cancer. It is similar in its activity to finasteride (found in Proscar or Propecia), having almost identical areas of application. Avodart has been approved to treating benign prostatic enlargement and is being studied for its use in treating male pattern baldness. The Korean clinical trial by GlaxoSmithKline has been completed about a year and a half ago but its results have not yet been released to the public scrutiny and, therefore, Avodart has not been approved for treating male pattern baldness. The main concern is not its efficacy but its side effects. Many hair loss patients buy Avodart online and they have confirmed the fact that it is a more powerful pill than Propecia (finasteride) in regrowing hair, especially in the front of the scalp. The big question mark is its side effects, which are supposed to be more pronounced than for finasteride as dutasteride is a dual 5-alpha reductase inhibitor.

A recently conducted study of dutasteride by GlaxoSmithKline showed that Avodart (dutasteride) is effective in reducing the risk of prostate cancer, which makes it appear yet more like finasteride. Although there is no consensus among the physicians on whether dutasteride, or any other hormone-blocking medication, should be used to prevent cancer, some doctors suggest it might be prudent to use dutasteride in some very high risk patients. Another interesting finding of this recent study is an increased incidence of heart failure in patients treated by dutasteride, which needs further examination but does not add more credibility to Avodart (dutasteride) due to its long list of potential side-effects.